| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3419377 | Revue de Pneumologie Clinique | 2015 | 7 Pages |
Abstract
In the setting of emerging MDR-TB, tuberculin skin test may be likely replaced by specific interferon-gamma release assays (IGRA), independent of prior BCG vaccination. In addition, chest CT scan is preferred to chest X-ray to detect TB lesions. The management of latent TB infection is controversial: immediate treatment with second-line anti-TB drugs adapted to the index case strain or, consistently with WHO guidelines, a simple follow-up with subsequent treatment in case of active TB.
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
G. Catho, A. Sénéchal, A.-S. Ronnaux-Baron, F. Valour, T. Perpoint, A. Bouaziz, O. Dumitriescu, P. Reix, C. Pedone, F. Ader, Lyon TB Study Group Lyon TB Study Group,
